📢 Highlights from March 24 to 31 in the world of pharma and healthcare! 🗞️👀

Vyuhpharma Sungen (FDA, FTD) FDA grants Fast Track designation to Sungen Biomedical's SGC001 mAb for acute myocardial infarction Sermonix + Regor (Partnership) Sermonix and Regor partner to enhance rCARD platform for advancing breast oncology therapeutics Palatin (FDA, ODD) FDA grants Orphan Drug Status to Palatin's PL7737 for treating obesity from leptin receptor deficiency Vast (FDA, QIDP) FDA grants QIDP designation to Vast's ALX1 for targeting pseudomonas and other critical pathogens

Connect with us

Please fill in the information below, and we'll get back to you.